The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 25, 2018
Filed:
Jan. 23, 2014
Applicants:
National University of Singapore, Singapore, SG;
Nanyang Technological University, Singapore, SG;
Inventors:
Vincent Tak Kwong Chow, Singapore, SG;
Nguan Soon Tan, Singapore, SG;
Liang Li, Singapore, SG;
Ming Jie Tan, Singapore, SG;
Han Chung Kelvin Chong, Singapore, SG;
Assignees:
National University of Singapore, Singapore, SG;
Nanyang Technological University, Singapore, SG;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/53 (2006.01); A61K 39/395 (2006.01); A61K 45/00 (2006.01); C07K 16/22 (2006.01); G01N 33/569 (2006.01); G01N 33/68 (2006.01); C12Q 1/6883 (2018.01); A61K 49/00 (2006.01); G01N 33/74 (2006.01); G06F 19/12 (2011.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/22 (2013.01); A61K 49/0008 (2013.01); C12Q 1/6883 (2013.01); G01N 33/56911 (2013.01); G01N 33/68 (2013.01); G01N 33/74 (2013.01); G06F 19/12 (2013.01); A61K 2039/505 (2013.01); C07K 2317/21 (2013.01); C07K 2317/24 (2013.01); C07K 2317/34 (2013.01); C12Q 2600/106 (2013.01); C12Q 2600/118 (2013.01); C12Q 2600/158 (2013.01); G01N 2333/515 (2013.01); G01N 2500/04 (2013.01); G01N 2500/20 (2013.01); G01N 2800/50 (2013.01); G01N 2800/52 (2013.01); G01N 2800/70 (2013.01); G01N 2800/7095 (2013.01);
Abstract
The invention relates to the C-terminal fragment of angiopoietin-related protein 4 [cAngptl4] as a diagnostic marker for viral and bacterial pneumonia; anti-angiopoietin-related protein 4 therapeutic antibodies, and the use of anti-angiopoietin-related protein 4 antibodies in the treatment of viral and bacterial pneumonia.